The prexy of Acerus Pharma describes three significant challenges facing pharmaceutical leadership (620 words, 3 minutes)
and
The Evolution of Pharma LeadershipListen now (33 min) | In the bonus episode of the NPC Podcast, guest host Tiana DiMichele talks with Ed Gudaitis, President & CEO of Acerus Pharma, and…
Ken Chan is working to overcome vaccine hesitancy, and thinks mandates might be the way forward (450 words, 3 min)
S05 E08 Combating Covid-19 Vaccine HesitancyListen now (21 min) | In the eighth and final episode of our fifth season, our host Peter Brenders talks with Ken Chan, VP Admin at Brock University, a…
Martine Elias describes the ongoing impact of the pandemic on immunocompromised cancer patients (400 words, 2.5 min)
S05 E07 How Covid-19 Disrupted Cancer Patient CareListen now (24 min) | In the seventh episode of our fifth season, our host Peter Brenders talks with Martine Elias, Executive Director of Myeloma Canad…
Tracy Clinch's New Brunswick company is on guard for vital—and expensive—pharmaceutical products (400 words, 2.5 min)
S05 E06 Preventative Measures for the Pharmaceutical Production LineListen now (18 min) | In the sixth episode of our fifth season, our host Peter Brenders talks with Tracy Clinch, Founder & CEO of Masitek Instruments I…
Life Sciences Ontario's Dr. Jason Field gives his perspective on how the pandemic has re-shaped the Canadian industry
S05 E05 The Post-Pandemic Life Sciences LandscapeListen now (19 min) | In the fifth episode of our fifth season, our host Peter Brenders talks with Dr. Jason Field, President & CEO of Life Sciences On…
Dr. Blake Pearson wants to make medical cannabis accessible to a broader patient population (400 words, 2.5 min)
S05 E04 The Emerging Role of Medical CannabisListen now (17 min) | In the fourth episode of our fifth season, our host Peter Brenders talks with Dr. Blake Pearson, founder of Greenly Health and Pe…